Genomma Lab (Mexico) Analysis
| LABB Stock | MXN 17.76 0.16 0.89% |
Genomma Lab Internacional holds a debt-to-equity ratio of 0.613. With a high degree of financial leverage come high-interest payments, which usually reduce Genomma Lab's Earnings Per Share (EPS).
Asset vs Debt
Equity vs Debt
Genomma Lab's liquidity is one of the most fundamental aspects of both its future profitability and its ability to meet different types of ongoing financial obligations. Genomma Lab's cash, liquid assets, total liabilities, and shareholder equity can be utilized to evaluate how much leverage the Company is using to sustain its current operations. For traders, higher-leverage indicators usually imply a higher risk to shareholders. In addition, it helps Genomma Stock's retail investors understand whether an upcoming fall or rise in the market will negatively affect Genomma Lab's stakeholders.
For most companies, including Genomma Lab, marketable securities, inventories, and receivables are the most common assets that could be converted to cash. However, for Genomma Lab Internacional, the most critical issue when managing liquidity is ensuring that current assets are properly aligned with current liabilities. If they are not, Genomma Lab's management will need to obtain alternative financing to ensure there are always enough cash equivalents on the balance sheet to meet obligations.
Given that Genomma Lab's debt-to-equity ratio measures a Company's obligations relative to the value of its net assets, it is usually used by traders to estimate the extent to which Genomma Lab is acquiring new debt as a mechanism of leveraging its assets. A high debt-to-equity ratio is generally associated with increased risk, implying that it has been aggressive in financing its growth with debt. Another way to look at debt-to-equity ratios is to compare the overall debt load of Genomma Lab to its assets or equity, showing how much of the company assets belong to shareholders vs. creditors. If shareholders own more assets, Genomma Lab is said to be less leveraged. If creditors hold a majority of Genomma Lab's assets, the Company is said to be highly leveraged.
Genomma Lab Internacional is fairly valued with Real Value of 17.79 and Hype Value of 17.76. The main objective of Genomma Lab stock analysis is to determine its intrinsic value, which is an estimate of what Genomma Lab Internacional is worth, separate from its market price. There are two main types of Genomma Lab's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Genomma Lab's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Genomma Lab's stock to identify patterns and trends that may indicate its future price movements.
The Genomma Lab stock is traded in Mexico on Mexican Exchange, with the market opening at 08:30:00 and closing at 15:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in Mexico. Genomma Stock trading window is adjusted to America/Mexico City timezone.
Genomma |
Genomma Stock Analysis Notes
About 29.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 1.51. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Genomma Lab Internacional last dividend was issued on the 9th of November 2022. The entity had 2:1 split on the 3rd of August 2010. Genomma Lab Internacional, S.A.B. de C.V. together with its subsidiaries, engages in the development, marketing, and sale of over-the-counter pharmaceutical and personal care products in Mexico, the United States, and Latin America. Genomma Lab Internacional, S.A.B. de C.V. was founded in 1996 and is based in Mexico City, Mexico. GENOMMA LAB operates under Drug ManufacturersSpecialty Generic classification in Mexico and is traded on Mexico Stock Exchange. It employs 1451 people. To find out more about Genomma Lab Internacional contact Jorge Valderrama at 52 55 5081 0000 or learn more at https://www.genommalab.com.Genomma Lab Internacional Investment Alerts
| About 29.0% of the company outstanding shares are owned by corporate insiders |
Genomma Market Capitalization
The company currently falls under 'Large-Cap' category with a current market capitalization of 18.09 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Genomma Lab's market, we take the total number of its shares issued and multiply it by Genomma Lab's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Genomma Profitablity
Genomma Lab's profitability indicators refer to fundamental financial ratios that showcase Genomma Lab's ability to generate income relative to its revenue or operating costs. If, let's say, Genomma Lab is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Genomma Lab's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Genomma Lab's profitability requires more research than a typical breakdown of Genomma Lab's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of 0.08 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.2 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.2. Technical Drivers
As of the 6th of January, Genomma Lab retains the Risk Adjusted Performance of (0.03), standard deviation of 1.79, and Market Risk Adjusted Performance of (0.18). Concerning fundamental indicators, the technical analysis model lets you check existing technical drivers of Genomma Lab Internacional, as well as the relationship between them.Genomma Lab Internacional Price Movement Analysis
The output start index for this execution was two with a total number of output elements of fifty-nine. The Simple Moving Average indicator is calculated by adding the closing price of Genomma Lab for a given number of time periods and then dividing this total by the number of time periods. It is used to smooth out Genomma Lab Internacional short-term fluctuations and highlight longer-term trends or cycles.
Genomma Lab Outstanding Bonds
Genomma Lab issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Genomma Lab Internacional uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Genomma bonds can be classified according to their maturity, which is the date when Genomma Lab Internacional has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View |
Genomma Lab Predictive Daily Indicators
Genomma Lab intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Genomma Lab stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Genomma Lab Forecast Models
Genomma Lab's time-series forecasting models are one of many Genomma Lab's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Genomma Lab's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.Genomma Lab Internacional Debt to Cash Allocation
Genomma Lab Internacional has accumulated 3.83 B in total debt with debt to equity ratio (D/E) of 0.61, which is about average as compared to similar companies. Genomma Lab Internacional has a current ratio of 1.72, which is within standard range for the sector. Debt can assist Genomma Lab until it has trouble settling it off, either with new capital or with free cash flow. So, Genomma Lab's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Genomma Lab Internacional sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Genomma to invest in growth at high rates of return. When we think about Genomma Lab's use of debt, we should always consider it together with cash and equity.Genomma Lab Assets Financed by Debt
Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the Genomma Lab's operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of Genomma Lab, which in turn will lower the firm's financial flexibility.Genomma Lab Corporate Bonds Issued
About Genomma Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Genomma Lab prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Genomma shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Genomma Lab. By using and applying Genomma Stock analysis, traders can create a robust methodology for identifying Genomma entry and exit points for their positions.
Genomma Lab Internacional, S.A.B. de C.V. together with its subsidiaries, engages in the development, marketing, and sale of over-the-counter pharmaceutical and personal care products in Mexico, the United States, and Latin America. Genomma Lab Internacional, S.A.B. de C.V. was founded in 1996 and is based in Mexico City, Mexico. GENOMMA LAB operates under Drug ManufacturersSpecialty Generic classification in Mexico and is traded on Mexico Stock Exchange. It employs 1451 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Genomma Lab to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Idea Breakdown Now
Idea BreakdownAnalyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |
| All Next | Launch Module |
Additional Tools for Genomma Stock Analysis
When running Genomma Lab's price analysis, check to measure Genomma Lab's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genomma Lab is operating at the current time. Most of Genomma Lab's value examination focuses on studying past and present price action to predict the probability of Genomma Lab's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genomma Lab's price. Additionally, you may evaluate how the addition of Genomma Lab to your portfolios can decrease your overall portfolio volatility.